Literature DB >> 7868814

Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas.

M Marazuela1, B Astigarraga, A Vicente, J Estrada, C Cuerda, J García-Uría, T Lucas.   

Abstract

A series of 35 patients with non-functioning pituitary adenomas undergoing transsphenoidal surgery is presented. In most cases, the presenting symptoms were related to the mass effect of the tumor. There was no operative mortality. Before surgery, visual field defects were documented in 21 patients (60%). After surgery, excluding 3 patients with preoperative blindness, 28% regained normal vision and 67% showed variable improvement. Preoperatively, 24 patients (69%) had abnormal pituitary function, 24 (69%) had hypogonadism, 7 (20%) adrenal insufficiency, 8 (23%) hypothyroidism and 2 (6%) panhypopituitarism. After pituitary surgery, all but one patient with normal preoperative function retained it. Of the patients with hypopituitarism, 11 (46%) had variable improvement and 13 (54%) had persistent deficits. After surgery, 4 patients (57%) with adrenal insufficiency recovered normal adrenal function, 7 patients (29%) with hypogonadism recovered gonadal function and 1 patient (13%) with hypothyroidism recovered thyroid function. Prior to surgery, the presence of a normal or slightly elevated PRL and a rise in TSH after TRH and in LH after GnRH stimulation were of value in predicting possible recovery of pituitary function after surgery. These observations suggest the presence of viable pituitary tissue in these cases and point out that, in some instances, the mechanism of hypopituitarism may be compression of the portal circulation, rather than destruction of the normal pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7868814     DOI: 10.1007/BF03347763

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.

Authors:  B M Arafah
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

2.  Improvement of pituitary function after surgical decompression for pituitary tumor apoplexy.

Authors:  B M Arafah; J F Harrington; Z T Madhoun; W R Selman
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

3.  Visual recovery after transsphenoidal removal of pituitary adenomas.

Authors:  A R Cohen; P R Cooper; M J Kupersmith; E S Flamm; J Ransohoff
Journal:  Neurosurgery       Date:  1985-09       Impact factor: 4.654

4.  Acromegaly. Treatment by transsphenoidal microsurgery.

Authors:  R L Atkinson; D P Becker; A N Martins; M Schaaf; R C Dimond; L Wartofsky; J M Earll
Journal:  JAMA       Date:  1975-09-22       Impact factor: 56.272

5.  Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas. A review of 137 cases.

Authors:  D S Baskin; J E Boggan; C B Wilson
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

6.  Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas.

Authors:  M A Faria; G T Tindall
Journal:  J Neurosurg       Date:  1982-01       Impact factor: 5.115

7.  Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results.

Authors:  I Ciric; M Mikhael; T Stafford; L Lawson; R Garces
Journal:  J Neurosurg       Date:  1983-09       Impact factor: 5.115

8.  Functional treatment of acromegaly by transsphenoidal microsurgery.

Authors:  J García-Uría; J M del Pozo; G Bravo
Journal:  J Neurosurg       Date:  1978-07       Impact factor: 5.115

9.  The treatment of acromegaly by transsphenoidal surgery.

Authors:  H S Tucker; S R Grubb; J P Wigand; C O Watlington; W G Blackard; D P Becker
Journal:  Arch Intern Med       Date:  1980-06

10.  Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas.

Authors:  M J Ebersold; L M Quast; E R Laws; B Scheithauer; R V Randall
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

View more
  25 in total

Review 1.  Treatment of pituitary tumors: surgery.

Authors:  Michael Buchfelder
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

2.  Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

Authors:  P Cappabianca; A Alfieri; A Colao; D Ferone; G Lombardi; E de Divitiis
Journal:  Skull Base Surg       Date:  1999

Review 3.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

Review 4.  Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

Review 5.  Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

Authors:  Georgia Ntali; John A Wass
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

6.  Volumetric measurement for comparison of the accuracy between intraoperative CT and postoperative MR imaging in pituitary adenoma surgery.

Authors:  C-C Lee; S-T Lee; C-N Chang; P-C Pai; Y-L Chen; T-C Hsieh; C-C Chuang
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

7.  Factors influencing improvement of visual field after trans-sphenoidal resection of pituitary macroadenomas: a retrospective cohort study.

Authors:  Fen-Fen Yu; Li-Li Chen; Yi-Hua Su; Li-Hun Huo; Xian-Xuan Lin; Rui-Duan Liao
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

8.  Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method.

Authors:  Lina Raffaella Barzaghi; Marzia Medone; Marco Losa; Stefania Bianchi; Massimo Giovanelli; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-11-15       Impact factor: 3.042

Review 9.  Aetiology, diagnosis, and management of hypopituitarism in adult life.

Authors:  V K B Prabhakar; S M Shalet
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

10.  Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors.

Authors:  Nader Sanai; Alfredo Quiñones-Hinojosa; Jared Narvid; Sandeep Kunwar
Journal:  J Neurooncol       Date:  2007-12-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.